Search clinical trials for: Left Ventricular Mass (LVM)

Total 35622 results

Azienda Ospedaliera, Universitaria Policlinico...
Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy

Unknown

Stenting of Renal Artery Stenosis in Coronary Artery Disease Study (RASCAD)

Renal Artery Stenosis | Left Ventricular Hypertrophy

Italy
Hanmi Pharmaceutical Company Limited

Completed

Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease

Hypertension | Aortic Stenosis | Aortic Regurgitation | Left Ventricular Hypertrophy | LVM

Korea, Republic of
Xiang Guang-da

Completed

Pioglitazone Regress Left Ventricular Mass in Type 2 Diabetes With Ischeamia Heart Disease

Endothelial Function | LVM | Type 2 Diabetic Patients With IHD

China
Forest Laboratories

Completed

Safety Study of F2695 SR in Major Depressive Disorder (LVM-MD-04)

Major Depressive Disorder

United States
Forest Laboratories

Completed

Relapse-Prevention Study With Levomilnacipran ER (F2695 SR) in Patients With Major Depressive Disorder

Depression | Major Depressive Disorder

United States, Canada
Forest Laboratories

Completed

Safety and Efficacy of Levomilnacipran ER (Levomilnacipran SR) in Major Depressive Disorder

Major Depressive Disorder

United States, Canada
Forest Laboratories

Completed

A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder

Depressive Disorder, Major

United States
Forest Laboratories

Completed

Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Adults With Fatigue Associated With Major Depressive Disorder

Major Depressive Disorder

United States
Forest Laboratories

Completed

Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder

Major Depressive Disorder

United States
Allergan

Completed

Efficacy, Safety, and Tolerability of Levomilnacipran ER in Pediatric Patients (7-17 Years) With Major Depressive Disorder

Major Depressive Disorder

United States
Forest Laboratories

Completed

Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder

Major Depressive Disorder

United States
Forest Laboratories

Completed

Safety and Efficacy of Levomilnacipran ER in Adolescent Participants With Major Depressive Disorder

Major Depressive Disorder

United States, Puerto Rico
Forest Laboratories

Completed

Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder

Major Depressive Disorder

United States
University of Sao Paulo General Hospital

Unknown

Renal Transplantation in the Elderly - nEverOld Study

Renal Transplant Rejection | Graft Failure | Transplant; Failure, Kidney | Chronic Renal Failure (CRF)

Brazil
Novartis Pharmaceuticals

Completed

ALiskiren or Losartan Effects on bioMARKers of Myocardial Remodeling (ALLMARK)

Hypertension | Left Ventricle Hypertrophy

Spain
University Hospital of Ferrara

Recruiting

ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System Pacing (TREEBEARD)

Atrial Fibrillation | Arrhythmias, Cardiac | Left Bundle-Branch Block | Bundle-Branch Block | Ventricular Fibrillation | Ventricular Tachycardia | Ventricular Dysfunction | Atrioventricular Block | Heart Failure, Systolic | Ventricular Arrythmia | Heart Failure，Congestive | Bradyarrhythmia | Heart Arrhythmia | Reduced... and other conditions

Italy
National Taiwan University Hospital
Shin Kong Wu Ho-Su Memorial Hospital

Not yet recruiting

Empagliflozin in Heart Failure With Reduced Ejection Fraction and End Stage Renal Disease (EMPA-RRED)

Heart Failure With Reduced Ejection Fraction | End Stage Renal Disease on Dialysis
Massachusetts General Hospital
Medtronic

Recruiting

The Boston Pace Study

Left Bundle Branch Area Pacing

United States
Kiyuk Chang
Seoul St. Mary's Hospital; Pusan National University Hospital; Korea University... and other collaborators

Recruiting

SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients With Acute Myocardial Infarction, a Prospective, Multi-center Registry Study (RECORD-AMI)

Myocardial Infarction | Diabetes Mellitus, Type 2

Korea, Republic of
Centro Cardiologico Monzino

Recruiting

Effects of Dapagliflozin on Cardiorespiratory Parameters in Heart Failure

Heart Failure | Sleep Apnea | Heart Failure With Reduced Ejection Fraction | Cardiopulmonary Exercise Test | Left Ventricle Remodeling

Italy
Istituto Auxologico Italiano
Philips Healthcare

Recruiting

Assessment of Left Ventricular Filling Pressure by Applying Artificial Intelligence Algorithms to Left Atrial Speckle-tracking Echocardiography (LVEDP)

Heart Failure, Diastolic | Echocardiography

United States
Brigham and Women's Hospital

Recruiting

Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension

Hypertension | Left Ventricular Hypertrophy

United States
Instituto Ecuatoriano del Corazón

Recruiting

Cumulative Blood Pressure Load and Left Ventricular Mass

Arterial Hypertension

Ecuador
Sunnybrook Health Sciences Centre
Canadian Institutes of Health Research (CIHR); Weill Medical College of Cornell...

Recruiting

The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)

Coronary Artery Disease | Heart Failure Systolic

United States, Canada, Serbia, Poland, Austria, China, Spain, Croatia, India, Italy
Sanofi

Recruiting

A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry Disease (CARAT)

Fabry Disease

Italy, United States, Austria, China, Czechia, Denmark, France, Germany, Greece, Japan, Korea, Republic of, Netherlands, Norway, Spain, Taiwan, Turkey, United Kingdom, Canada, Poland
Impulse Dynamics

Recruiting

Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer)

Heart Failure | Heart Failure With Preserved Ejection Fraction | Diastolic Heart Failure | Heart Failure With Mid Range Ejection Fraction | Heart Failure With Moderately Reduced Ejection Fraction

United States
Abiomed Inc.

Recruiting

Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function (PROTECT IV)

Coronary Artery Disease | Left Ventricular Dysfunction

United States, Switzerland, Germany, Canada, Italy, Netherlands, United Kingdom
Massachusetts General Hospital

Recruiting

Imaging Histone Deacetylase in the Heart

Diabetes | Aortic Valve Stenosis | Heart Failure With Normal Ejection Fraction | Left Ventricular Hypertrophy

United States
Brigham and Women's Hospital
CSL Behring

Recruiting

Assessment of Coagulation Factor Levels in Left Ventricular Device (LVAD )Patients Following Temporary Warfarin Reversal With Four Factor Prothrombin Complex Concentrate (4F-PCC) (KVAD)

Anticoagulation | Anticoagulation Reversal

United States
Cambridge University Hospitals NHS Foundation Trust
University of Cambridge

Recruiting

Influence of Age, Weight and Ethnic Background on Blood Pressure (AWE)

Cardiovascular Diseases | Vascular Diseases | Hypertension

United Kingdom
Massachusetts General Hospital

Recruiting

Diffusion MRI in Heart Failure

Myocardial Infarction | Heart Failure | Left Ventricular Hypertrophy

United States
Evaheart, Inc.

Recruiting

Prospective Multi-Center Randomized Study for Evaluating the EVAHEART®2 Left Ventricular Assist System (COMPETENCE)

Heart Failure

United States
Brigham and Women's Hospital
Harvard Medical School (HMS and HSDM); National Heart, Lung, and Blood Institute... and other collaborators

Recruiting

TRANSCRIBE (Transcriptomic Analysis of Left Ventricular Gene Expression)

Cardiovascular Diseases

United States
Bayer

Active, not recruiting

A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction (LEPHT)

Hypertension, Pulmonary | Ventricular Dysfunction, Left

Belgium, France, China, Spain, Japan, United States, Singapore, Canada, Switzerland, Austria, Denmark, Germany, Italy, Australia, Czechia, Netherlands, Poland, United Kingdom
University of Edinburgh
Chief Scientist Office of the Scottish Government

Active, not recruiting

Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction (TARGET-Type 2)

Myocardial Infarction Type 2

United Kingdom
Capricor Inc.
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health... and other collaborators

Terminated

Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration (ALLSTAR)

Myocardial Infarction

United States
Abiomed Inc.

Active, not recruiting

Impella ECP Early Feasibility Study (ECP EFS)

High-risk Percutaneous Coronary Intervention

United States
Bristol-Myers Squibb

Active, not recruiting

A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM

Hypertrophic Cardiomyopathy | Non-obstructive Hypertrophic Cardiomyopathy | Obstructive Hypertrophic Cardiomyopathy

Denmark, United States, Belgium, Czechia, France, Germany, Israel, Italy, Netherlands, Poland, Portugal, Spain, United Kingdom
Novo Nordisk A/S

Completed

Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients

Growth Hormone Disorder | Adult Growth Hormone Deficiency

France
Abiomed Inc.

Enrolling by invitation

Impella ECP Study (ECP Study) and Impella ECP Continued Access Protocol

High-Risk Percutaneous Coronary Intervention

United States
Abiomed Inc.

Enrolling by invitation

IMpella-Protected cArdiaC Surgery Trial (IMPACT) (IMPACT)

Left Ventricular Dysfunction

United States
Craig L Slingluff, Jr
Celldex Therapeutics

Active, not recruiting

Melanoma Vaccine Against Neoantigen and Shared Antigens by CD40 Activation and TLR Agonists In Patients With Melanoma (Including Ocular Melanoma) (Mel66)

Melanoma | Ocular Melanoma | Uveal Melanoma

United States
Heart Test Laboratories, Inc.

Active, not recruiting

MyoVista wavECG Clinical Validation Study Versus Low e' on Echocardiogram

Cardiac Disease

United States
Centre Hospitalier Universitaire, Amiens

Completed

4D-flow MRI to Assess Left Ventricular Obstruction in Hypertrophic Cardiomyopathy (CMHFLUX)

Hypertrophic Cardiomyopathy | Obstruction | Echocardiography

France
Cairo University

Completed

Efficacy of Metformin as add-on Therapy in Non-Diabetic Heart Failure Patients

Heart Failure

Egypt
Cardiovascular Research Foundation, New York
Cardialysis BV; Avania

Active, not recruiting

Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD)

Aortic Valve Stenosis

United States, Canada, Netherlands
Massachusetts General Hospital

Enrolling by invitation

Effect of a Targeted Notification and Clinical Support Pathway on Individuals With Left Ventricular Hypertrophy (NOTIFY-LVH)

Hypertension | Cardiomyopathies | Hypertrophy, Left Ventricular

United States
University Hospital, Limoges

Withdrawn

Efficacy of Angiotensin Receptor Blocker Following aortIc Valve Intervention for Aortic STenOsis: a Randomized mulTi-cEntric Double-blind Phase II Study (ARISTOTE)

Aortic Valve Stenosis | Transcatheter Aortic Valve Replacement | Hypertrophy, Left Ventricular | Angiotensin Receptor Antagonists | Heart Valve Prosthesis Implantation | Valsartan

France
Brigham and Women's Hospital
National Heart, Lung, and Blood Institute (NHLBI); Northwestern University; Quintiles... and other collaborators

Active, not recruiting

PRE-DETERMINE Cohort Study

Coronary Artery Disease | Sudden Cardiac Death | Left Ventricular Dysfunction

United States, Canada, Puerto Rico
Abbott Medical Devices

Active, not recruiting

Implantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical SWIFT HM3 PMS (SWIFT)

Advanced Refractory Left Ventricular Heart Failure

United States, Canada

Search clinical trials for: Left Ventricular Mass (LVM)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations